论文信息 - Sequential Therapy with Cytarabine and Bismuth-213 (213Bi)-Labeled-HuM195 (Anti-CD33) for Acute Myeloid Leukemia (AML). - 字舞流文

Sequential Therapy with Cytarabine and Bismuth-213 (213Bi)-Labeled-HuM195 (Anti-CD33) for Acute Myeloid Leukemia (AML).

S. Larson | D. Scheinberg | M. McDevitt | C. Apostolidis | R. Finn | C. Divgi | N. Pandit-Taskar | J. Jurcic | A. Morgenstern | M. Weiss | D. Mulford